A promise to protect the exclusive value and treatment competitiveness of partner Korean medicine clinics
Have you ever experienced treatment prices being destroyed and internal credibility declining due to the indiscriminate distribution of hospital-exclusive products on online shopping malls or open markets?
THE YOOL LAB has adhered to one firm principle since the early days of its brand launch.
It is the ‘Clinic-Exclusive‘ distribution policy.
1. Protection from indiscriminate distribution chaos and price wars
All of The Yul Lab’s high-performance solutions and medical lineups are not supplied through general online distribution channels (open markets, general consumer goods malls, etc.).
- Price Protection: Prevents the decline in the value of in-clinic procedures caused by the proliferation of online prices.
- Protection of Expertise: Guarantees scarcity as a ‘medical professional asset’ accessible only through the accurate diagnosis and prescription of Korean medicine practitioners.
2. A close, comprehensive support system that does not simply supply products
The Yul Lab does not remain merely a product vendor. We provide a close, comprehensive support system to ensure that our partner Korean medicine clinics successfully integrate our products into their facilities.
- 1:1 Customized In-Hospital Practical Training: Field-oriented practical training for the Director and in-hospital medical staff
- Regular Academic Seminar: Sharing the Latest Clinical Data and Procedure Know-how
- In-Hospital Marketing Kit: High-quality banners, patient brochures, in-hospital X-banners, and support for academic reports
3. A sustainable B2B mutual growth platform for shared growth
The Yul Lab can only grow together with our partner clinics. The Yul Lab actively gathers feedback from the field from clinic directors and incorporates it into new product development and the advancement of AI diagnostic protocols.
The Yul Lab promises to be a sustainable B2B mutual growth partner that protects the value of Korean medicine clinics and supports the director’s clinical competitiveness most closely.